Skip to content

Clinical trials

Phase 2 Adenocarcinoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20083
20093
20121
20142
20151
20162
20181
20202
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting4
Terminated4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AstraZeneca1
Boston Scientific Corporation1
Bristol-Myers Squibb1
EMD Serono Research & Development Institute, Inc.1
Elevation Oncology1
Genentech, Inc.1
Grupo Espanol Multidisciplinario del Cancer Digestivo1
Grupo Espanol de Tumores Neuroendocrinos1
Hospital Arnau de Vilanova1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma22
Carcinoma, Non-Small-Cell Lung6
Carcinoma5
Neoplasm Metastasis4
Esophageal Neoplasms3
Stomach Neoplasms3
Carcinoma, Renal Cell2
Colonic Neoplasms2
Colorectal Neoplasms2
Lung Neoplasms2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.